comparemela.com

Latest Breaking News On - Cellresearch corporation - Page 1 : comparemela.com

Data Vantage: Plugo, Salary Board bag funding; iCandy fully acquires Storms

iCandy has fully acquired Storms after buying all the remaining shares it did not own from SK Telecom.

Republic ofSouth koreaSouth koreanFermin diezChoon keatSatish shankarRheza adhihusadaFlorian hoppeSoegeng wibowoSuvir varmaCellresearch corporationSk telecomAltos venturesBonangels venture partnersCandy interactiveIntudo ventures

CellResearch Corporation (CRC) to present promising new stem cell products for the treatment of chronic diabetic foot ulcers at the world s premier diabetic foot conference (DFCon) in Los Angeles

- CRC data on cord lining media for the treatment of diabetic foot ulcers has been accepted at the DFCon, with Dr Wong Keng Lin Francis, CRC s latest KOL,.

United statesLos angelesWong keng lin francisDavid armstrongXavier simpsonPaul kempCellresearch corporationUniversity of coloradoMenarini groupCellresearch corpBusiness developmentCellresearch consumer healthCecilia low wangSengkang generalResearch corporationAge related macular degeneration

CellResearch Corporation reports positive results of DFU trial

CellResearch Corporation has closed the first phase I study for CorLiCyte, a stem cell therapy derived from umbilical cord lining stem cells.

United statesCellresearch corporationUniversity of coloradoAcoording to university of michigan healthAnschutz medical campusClinimmune cellCecilia low wangAnschutz medicalMichigan healthResearch corporation

Positive results from CellResearch Corporation diabetic foot ulcer study

CellResearch Corporation has closed the first phase I study for CorLiCyte, a stem cell therapy derived from umbilical cord lining stem cells.

United statesCellresearch corporationUniversity of coloradoAcoording to university of michigan healthAnschutz medical campusClinimmune cellCecilia low wangAnschutz medicalMichigan healthResearch corporation

CellResearch Corporation (CRC) announces positive results of Phase I study for CorLiCyte®

/PRNewswire/ CellResearch Corporation, a Singapore-based biopharmaceutical company today announced it has successfully closed the first Phase I study in.

United statesXavier simpsonCellresearch corporationUniversity of coloradoMenarini groupCellresearch consumer healthBusiness developmentAnschutz medical campusClinimmune cellCecilia low wangAnschutz medicalResearch corporationResearch consumer healthSouth eastInvestor relations

vimarsana © 2020. All Rights Reserved.